Premium Article

When We Might Consider Buying Some Ether

Anybody who tells you money is the root of all evil doesn’t have any. That line was dropped by Ben Affleck in his iconic Boiler Room speech which epitomizes the alpha male drive for money which characterized investment banking environments at the time. Money may not buy happiness, but there’s a correlation between depression and […]

SomaLogic Stock: A Significant First-Mover Advantage?

Proteomics – the study of proteins – is incredibly complex stuff. That’s why fund managers often hire subject matter experts to navigate such topics. We disagree with this approach. You cannot invest in what you know if you need an interpreter to do so. A simple understanding of the opportunity can suffice in most cases. […]

Confluent Stock: A Metaverse Big Data Play

Short-term stock price movements are nothing but noise, yet human emotion means we can’t help but check our portfolios every five minutes during market open. You’d think mainstream pundits would discourage such behavior, but they do anything but. Just look at this gem from Jim Cramer several days ago (our emphasis in bold). A year […]

Matterport Stock: A Richly Valued Metaverse Play

Probably the best thing to come out of the special purpose acquisition company (SPAC) era is a population of stocks that all started out at the same price point. This makes it exceptionally easy to gauge performance at a glance. That is until stocks start splitting, but we have a feeling the only splitting happening […]

A Legal Showdown: AutoStore vs Ocado Group

We recently wrote about the power of opensource software where a community of volunteers – like The Apache Foundation – can create billions of dollars in free software that helps advance technology in society. A similar ethos has been applied at Tesla where an open source patent pledge made in 2014 promises to “not initiate […]

Why Size Matters More for Tech Stocks

Our end-of-the-year portfolio review meeting ran into a brick wall almost immediately when one of our MBAs sparked up some Slurricane creeper that could have killed Elvis. Nonetheless, we powered our way through that hurdle, and started down the path of thinking more like portfolio managers and less like stoned MBAs. As risk-averse investors, we’re […]

Why We’re Avoiding Maxar Technologies Stock

There’s an entire contingent of twats on Twitter who think the way to be a successful investor is to find one stock they like and then cram it down everyone’s throats as if they’re selling Amway products. If you criticize their sacred cow in the slightest way, they become unhinged. A better way to use […]

LiveWire: A Pure-Play Electric Motorcycle Stock

Certain brands have unspoken connotations that society universally agrees upon. It’s why you never see a jacked-up dude driving a Prius with a dime piece in the passenger seat. A Prius is for the single guy with a dozen female friends he spends time courting, none of whom would touch him with a ten-foot pole. […]

Nearmap Stock: A Pure-Play on Aerial Imaging

In 2004, Blockbuster video had reached its peak with 9,000 brick-and-mortar stores worldwide and a new store opening every 17 hours. Today, there’s just one left in Bend Oregon – the last Blockbuster store. If you were an investor in Blockbuster at that time, what metrics would you have been watching to make sure you exited your […]

Trulieve Stock: The Good, The Bad, and The Ugly

We don’t just cover cannabis because we consume loads of the stuff in all forms. Our first piece on the topic – No to Marijuana Stocks, Yes to Weed Investing – was published in 2016 to warn investors about all the over-the-counter (OTC) junk stocks attaching themselves to the cannabis thesis like leeches. Our attempt […]